GLIA Advocacy Workshop and Scientific Meeting 2022

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is a consortium of scientists, industry stakeholders, and patient advocacy leaders working together to promote advances in the diagnosis and treatment of leukodystrophies.

To find out more about GLIA: The Global Leukodystrophy Initiative Website

They recently held a GLIA Advocacy Workshop and Scientific Meeting 2022 and the workshop recordings are now available to view.

To view the workshop recordings: 2022 GLIA Scientific Meeting Recordings